Patient Care | Clinical Trials | Trial

Guanfacine for Children with Tic Disorders

Conditions

Chronic Motor Tic Disorder | Chronic Vocal Tic Disorder | Tourette Syndrome

Trial Phase

Trial Purpose and Description

Trial Purpose

The Yale Child Study Center is recruiting subjects for a study of a new extended-release form of guanfacine (Intuniv®) in the treatment of tics in children with a Chronic Tic Disorder.

Participation Guidelines

Age:
6 Years - 16 Years
Gender:
Both

Eligibility Criteria

Inclusion Criteria:

  • At least 6 years old but younger than 17
  • Have a diagnosis of Tourette Syndrome or a chronic motor or vocal tic disorder
  • Not currently taking any stimulant medications or any medications for tics
Sponsor:
Shire Pharmaceuticals
Dates:
March 2012 - September 2013
Last Updated:
Study HIC#:
1006004435

Clinicaltrials.gov ID: Yale6138683